Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

HLA-a*0101 Expression Correlates with Increased Risk of Severe Cutaneous Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Maira Fonseca, MD, Ann A. Jakubowski, MD PhD, Sean M Devlin, PhD, James W. Young, MD, Samira A Fatmi, BS, Molly Maloy, MS, Sergio Giralt, MD, Doris Ponce, MD, Alina Markova, MD

Blood (2018) 132 (Supplement 1): 4564.

https://doi.org/10.1182/blood-2018-99-110405

Published: 2018

Journal Articles

Rash in Patients after T-Cell-Depleted Peripheral Blood Stem Cell Transplantation: Eosinophilia and Pruritus Do Not Distinguish Acute Graft-Versus-Host Disease from Drug Rash

Skylar A Klager, MS, Sean M Devlin, PhD, Margaret Hannum, MS, Ann A. Jakubowski, MD PhD, Alina Markova, MD

Blood (2018) 132 (Supplement 1): 4570.

https://doi.org/10.1182/blood-2018-99-110307

Published: 2018

Journal Articles

Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults

Richard J Lin, MD PhD, Theresa A Elko, MS, Patrick Hilden, MS, Parastoo B. Dahi, MD, Ann A. Jakubowski, MD PhD, Miguel-Angel Perales, MD, Juliet Barker, MBBS, H.R. Castro-Malaspina, MD, Brian C. Shaffer, MD, Armin Shahrokni, MD, Roni Tamari, MD, Esperanza B. Papadopoulos, MD, Craig S. Sauter, MD, Molly Maloy, MS, Beatriz Korc-Grodzicki, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 3370.

https://doi.org/10.1182/blood-2018-99-113876

Published: 2018

Journal Articles

CD34+Selected Hematopoietic Stem Cell Transplants Conditioned with a Myeloablative Regimen Is Well Tolerated and Results in Good Outcomes in Patients with Myelofibrosis

Jeong-Ok Lee, MD, Jessica Flynn, BS, Molly Maloy, MS, Ann A. Jakubowski, MD PhD, Esperanza B. Papadopoulos, MD, Christina Cho, MD, Doris Ponce, MD, Craig S. Sauter, MD, Miguel-Angel Perales, MD, Sean M Devlin, PhD, Sergio Giralt, MD, Hugo R. Castro-Malaspina, MD, Roni Tamari, MD

Blood (2018) 132 (Supplement 1): 4636.

https://doi.org/10.1182/blood-2018-99-113166

Published: 2018

Journal Articles

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Parastoo B. Dahi, MD, Chikaodi Obioha, Sheila Kenny, NP, Patrick Hilden, MS, Molly Maloy, MS, Alexander Geyer, MD, Wendy Schaffer, MD, Roni Tamari, MD, Craig S. Sauter, MD, Ann A. Jakubowski, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 4620.

https://doi.org/10.1182/blood-2018-99-112632

Published: 2018

Journal Articles

Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on Close Haplo-Winning CB Unit HLA-Match

Blood (2018) 132 (Supplement 1): 2078.

https://doi.org/10.1182/blood-2018-99-116276

Published: 2018

Journal Articles

A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Richard J Lin, MD PhD, Theresa A Elko, MS, Sean M Devlin, PhD, Ann A. Jakubowski, MD PhD, Armin Shahrokni, MD, Parastoo B. Dahi, MD, Miguel-Angel Perales, MD, Roni Tamari, MD, Brian C. Shaffer, MD, Craig S. Sauter, MD, Esperanza B. Papadopoulos, MD, H.R. Castro-Malaspina, MD, Juliet Barker, MBBS, Molly Maloy, MS, Beatriz Korc-Grodzicki, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 2176.

https://doi.org/10.1182/blood-2018-99-113688

Published: 2018

Journal Articles

CMV Reactivation Post CD34+ Selected Allo-HCT Has Adverse Outcomes on Blood Counts Recovery

Roni Tamari, MD, Christina Cho, MD, Patrick Hilden, MS, Taylor Borrill, BA, CCRP, Molly Maloy, MS, H.R. Castro-Malaspina, MD, Esperanza B. Papadopoulos, MD, Ann A. Jakubowski, MD PhD, Genovefa Papanicolaou, Sergio A. Giralt, MD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 3319.

https://doi.org/10.1182/blood.V130.Suppl_1.3319.3319

Published: 2017

Journal Articles

Efficacy of Donor Lymphocyte Infusion in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplant for Myeloid and Lymphoid Malignancies: A Single Center Experience

Adam Bryant, MD, Sean M. Devlin, PhD, H.R. Castro-Malaspina, MD, Ann A. Jakubowski, MD PhD, Molly Maloy, MS, Esperanza B. Papadopoulos, MD, Sergio A. Giralt, MD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 3277.

https://doi.org/10.1182/blood.V130.Suppl_1.3277.3277

Published: 2017

Journal Articles

Characterizing Ionizing Radiation Exposure after T-Cell Depleted Allogeneic Hematopoietic Cell Transplantation

Christina Cho, MD, Molly Maloy, MS, Sean M. Devlin, PhD, Omer Aras, MD, H.R. Castro-Malaspina, MD, Lawrence T. Dauer, PhD, Ann A. Jakubowski, MD PhD, Richard J. O'Reilly, MD, Esperanza B. Papadopoulos, MD, Miguel-Angel Perales, MD, Theodore S. Rappaport, PhD, Roni Tamari, MD, Marcel R.M. van den Brink, MD PhD, Sergio A. Giralt, MD

Blood (2017) 130 (Supplement 1): 5504.

https://doi.org/10.1182/blood.V130.Suppl_1.5504.5504

Published: 2017

Journal Articles

Impact of Omitting Post-Transplant Mini-Methotrexate Doses in Allogeneic Hematopoietic Cell Transplantation: A Single-Center Retrospective Study

Andrew Lin, PharmD, Patrick Hilden, MS, Molly Maloy, MS, Ann A. Jakubowski, MD PhD, Esperanza B. Papadopoulos, MD, Craig S. Sauter, MD, Roni Tamari, MD, Doris Ponce, MD, Sergio A. Giralt, MD, Boglarka Gyurkocza, MD

Blood (2017) 130 (Supplement 1): 3255.

https://doi.org/10.1182/blood.V130.Suppl_1.3255.3255

Published: 2017

Journal Articles

Long-Term Follow-up of Adult Double Unit Cord Blood (CB) Transplantation (dCBT) Recipients Reveals High Rates of Progression-Free Survival after a Novel Cy/ Flu/ Thio/ TBI 400 Intermediate Intensity Conditioning Regimen

Blood (2017) 130 (Supplement 1): 4589.

https://doi.org/10.1182/blood.V130.Suppl_1.4589.4589

Published: 2017

Journal Articles

Ex Vivo T Cell-Depleted and In Vivo T Cell-Depleted Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission Resulted in Similar Overall Survival Survival: On Behalf of the ALWP of the EBMT and the MSKCC

Florent Malard, MDPhD, Myriam Labopin, MD PhD, Christina Cho, MD, Didier Blaise, Esperanza B. Papadopoulos, MD, Jakob R. Passweg, MDMS, Richard O'Reilly, MD, Noel Milpied, Molly Maloy, MS, Liisa Volin, H.R. Castro-Malaspina, MD, Yosr Hicheri, Ann A. Jakubowski, MD PhD, Sylvie François, Sergio A. Giralt, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 4564.

https://doi.org/10.1182/blood.V130.Suppl_1.4564.4564

Published: 2017

Journal Articles

Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation

Kristen Beyer, PharmD, Anthony Proli, PharmD, Junting Zheng, Sean Devlin, PhD, Valkal Bhatt, PharmD, Andrew Lin, PharmD, Esperanza B. Papadopoulos, MD, Ann A. Jakubowski, MD PhD, Miguel Perales, MD, Sergio Giralt, MD, Hugo Castro-Malaspina, MD, Roni Tamari, MD

Blood (2016) 128 (22): 3392.

https://doi.org/10.1182/blood.V128.22.3392.3392

Published: 2016

Journal Articles

TP53 Mutations in AML Predict Adverse Outcome in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Bartlomiej M Getta, MBBS, Arnab Ghosh, MD PhD, Catherine C. Coombs, MD, Sean Devlin, PhD, Maria Arcila, MD, Abhinita Mohanty, Ross L. Levine, MD, Martin S. Tallman, MD, Ann A. Jakubowski, MD PhD, Sergio A. Giralt, MD, Alan M Hanash, MD PhD

Blood (2016) 128 (22): 3481.

https://doi.org/10.1182/blood.V128.22.3481.3481

Published: 2016

Journal Articles

The Disease Risk Index Predicts Outcomes Including Relapse and Survival in CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Christina Cho, MD, Patrick Hilden, MS, Jonathan U. Peled, MD PhD, Scott T. Avecilla, MD PhD, Pere Barba, MD, Juliet N. Barker, MBBS (Hons), Hugo R. Castro-Malaspina, MD, Sergio A. Giralt, MD, Ann A. Jakubowski, MD PhD, Guenther Koehne, MD PhD, Richard C. Meagher, PhD, Molly A. Maloy, MS, Richard J. O'Reilly, MD, Esperanza B. Papadopoulos, MD, Doris M. Ponce, MD, Marcel R. M. van den Brink, MD PhD, James W. Young, MD, Miguel-Angel Perales, MD

Blood (2016) 128 (22): 3498.

https://doi.org/10.1182/blood.V128.22.3498.3498

Published: 2016

Journal Articles

Selection of Unrelated Allogeneic Hematopoietic Cell Donors Based on KIR3DL1 Allotypes Is Feasible and Results in Improved Disease-Free Survival in Transplant Recipients with MDS and AML

Brian C. Shaffer, MD, Glenn Heller, PhD, Jean-Benoit Le Luduec, PhD, Jack Vahradian, Miguel Perales, MD, Sergio A. Giralt, MD, Roni Tamari, MD, Boglarka Gyurkocza, MD, Ann A. Jakubowski, MD PhD, E B Papadopoulos, MD, Jeanette E Boudreau, BSc, PhD, Nancy A. Kernan, MD, Katharine C. Hsu, MD PhD

Blood (2016) 128 (22): 990.

https://doi.org/10.1182/blood.V128.22.990.990

Published: 2016

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Patients with Myelodysplastic Syndromes

Bartlomiej Getta, MBBS,, Ashwin Kishtagari, MD, Patrick Hilden, MS, Sean Devlin, PhD, Molly A. Maloy, MS, Patrick K. Gonzales, Brian C. Shaffer, MD, Doris M Ponce, MD, Boglarka Gyurkocza, MD, Juliet N. Barker, MBBS, Esperanza B. Papadopoulos, MD, Hugo Castro-Malaspina, MD, Ann A. Jakubowski, MD PhD, James W. Young, MD, Martin S. Tallman, MD, Miguel-Angel Perales, MD, Sergio A. Giralt, MD, Roni Tamari, MD, Virginia M. Klimek, MD

Blood (2016) 128 (22): 3188.

https://doi.org/10.1182/blood.V128.22.3188.3188

Published: 2016

Journal Articles

A Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Hodgkin Lymphoma

Miguel-Angel Perales, MD, Christina Cho, MD, Anne Eaton, MS, Alison J Moskowitz, MD, Victoria Nguyen, BS, Anne Marie R. Gonzales-Dadiz, BS, Sean Devlin, PhD, Sergio A. Giralt, MD, Ann A. Jakubowski, MD PhD, Matthew J. Matasar, MD MS, Ariela Noy, MD, Carol S. Portlock, MD, David J. Straus, MD, James W. Young, MD, Juliet N. Barker, MBBS(Hons), FRACP, Craig H. Moskowitz, MD

Blood (2015) 126 (23): 4383.

https://doi.org/10.1182/blood.V126.23.4383.4383

Published: 2015

Journal Articles

Infection Burden of Double Stranded DNA (dsDNA) Viruses after CD34 + Selected, T-Cell Depleted (TCD) Hematopoietic Cell Transplantation (HCT) for Myeloid Malignancies at Memorial Sloan Kettering Cancer Center (MSK)

Yao-Ting Hayden Huang, PhD MPH, Seong Jin Kim, MPH, Yeon Joo Lee, MD MPH, Daniel Burack, BS, Paige Nichols, BA, Molly Maloy, MS, Roni Tamari, MD, Miguel-Angel Perales, MD, Sergio A. Giralt, MD, Hugo R. Castro-Malaspina, MD, Esperanza B Papadopoulos, MD, Ann A. Jakubowski, MD PhD, Genovefa A Papanicolaou, MD

Blood (2015) 126 (23): 4320.

https://doi.org/10.1182/blood.V126.23.4320.4320

Published: 2015

NARROW

HLA-a*0101 Expression Correlates with Increased Risk of Severe Cutaneous Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Rash in Patients after T-Cell-Depleted Peripheral Blood Stem Cell Transplantation: Eosinophilia and Pruritus Do Not Distinguish Acute Graft-Versus-Host Disease from Drug Rash

Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults

CD34+Selected Hematopoietic Stem Cell Transplants Conditioned with a Myeloablative Regimen Is Well Tolerated and Results in Good Outcomes in Patients with Myelofibrosis

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on Close Haplo-Winning CB Unit HLA-Match

A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

CMV Reactivation Post CD34+ Selected Allo-HCT Has Adverse Outcomes on Blood Counts Recovery

Efficacy of Donor Lymphocyte Infusion in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplant for Myeloid and Lymphoid Malignancies: A Single Center Experience

Characterizing Ionizing Radiation Exposure after T-Cell Depleted Allogeneic Hematopoietic Cell Transplantation

Impact of Omitting Post-Transplant Mini-Methotrexate Doses in Allogeneic Hematopoietic Cell Transplantation: A Single-Center Retrospective Study

Long-Term Follow-up of Adult Double Unit Cord Blood (CB) Transplantation (dCBT) Recipients Reveals High Rates of Progression-Free Survival after a Novel Cy/ Flu/ Thio/ TBI 400 Intermediate Intensity Conditioning Regimen

Ex Vivo T Cell-Depleted and In Vivo T Cell-Depleted Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission Resulted in Similar Overall Survival Survival: On Behalf of the ALWP of the EBMT and the MSKCC

Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation

TP53 Mutations in AML Predict Adverse Outcome in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

The Disease Risk Index Predicts Outcomes Including Relapse and Survival in CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Selection of Unrelated Allogeneic Hematopoietic Cell Donors Based on KIR3DL1 Allotypes Is Feasible and Results in Improved Disease-Free Survival in Transplant Recipients with MDS and AML

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Patients with Myelodysplastic Syndromes

A Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Hodgkin Lymphoma

Infection Burden of Double Stranded DNA (dsDNA) Viruses after CD34 + Selected, T-Cell Depleted (TCD) Hematopoietic Cell Transplantation (HCT) for Myeloid Malignancies at Memorial Sloan Kettering Cancer Center (MSK)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only